(Q34631179)

3 August 2017

1 reference

title

Cytokines and depression: an analogic approach (English)

1 reference

3 August 2017

M Corcos

1

1 reference

3 August 2017

O Guilbaud

2

1 reference

3 August 2017

L Hjalmarsson

3

1 reference

3 August 2017

J Chambry

4

1 reference

3 August 2017

Ph Jeammet

5

1 reference

3 August 2017

language of work or name

1 reference

1 March 2002

1 reference

Biomedicine and Pharmacotherapy

3 August 2017

published in

1 reference

3 August 2017

volume

56

1 reference

3 August 2017

issue

2

1 reference

3 August 2017

page(s)

105-110

1 reference

Receptors for interleukin-1 (α and β) in mouse brain: Mapping and neuronal localization in hippocampus

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900156-1

7 January 2021

Acute phase proteins in major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900156-1

7 January 2021

Synergy between tumor necrosis factor alpha and interleukin-1 in the induction of sickness behavior in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900156-1

7 January 2021

Blood levels of cytokines in elderly patients with major depressive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900156-1

7 January 2021

Induction of tryptophan degradation in vitro and in vivo: a gamma-interferon-stimulated activity

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900156-1

7 January 2021

Early depressive symptoms in cancer patients receiving interleukin 2 and/or interferon alfa-2b therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900156-1

7 January 2021

Systemic interleukin-1 administration stimulates hypothalamic norepinephrine metabolism parallelling the increased plasma corticosterone

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900156-1

7 January 2021

Serotonin and melatonin synthesis in peripheral blood mononuclear cells: stimulation by interferon-gamma as part of an immunomodulatory pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900156-1

7 January 2021

Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: effects of confounding factors and diagnosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900156-1

7 January 2021

Elevated levels of acute phase plasma proteins in major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900156-1

7 January 2021

Plasma concentrations of interleukin-1beta, interleukin-6, soluble interleukin-2 receptor and tumor necrosis factor alpha of depressed patients in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900156-1

7 January 2021

Cytokines and the brain: implications for clinical psychiatry

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900156-1

7 January 2021

Anti-Inflammatory effects of antidepressants through suppression of the interferon-gamma/interleukin-10 production ratio.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900156-1

7 January 2021

Cerebrospinal cytokine levels in patients with acute depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900156-1

7 January 2021

The role of inflammatory mediators in the biology of major depression: central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotection

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900156-1

7 January 2021

Higher alpha 1-antitrypsin, haptoglobin, ceruloplasmin and lower retinol binding protein plasma levels during depression: further evidence for the existence of an inflammatory response during that illness

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900156-1

7 January 2021

Relationships between interleukin-6 activity, acute phase proteins, and function of the hypothalamic-pituitary-adrenal axis in severe depression

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900156-1

7 January 2021

Psychomotor retardation, anorexia, weight loss, sleep disturbances, and loss of energy: psychopathological correlates of hyperhaptoglobinemia during major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900156-1

7 January 2021

Relationships between lower plasma L-tryptophan levels and immune-inflammatory variables in depression

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900156-1

7 January 2021

Interleukin-1 beta: a putative mediator of HPA axis hyperactivity in major depression?

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900156-1

7 January 2021

Evidence for an immune response in major depression: a review and hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900156-1

7 January 2021

Total serum protein and serum protein fractions in depression: relationships to depressive symptoms and glucocorticoid activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900156-1

7 January 2021

Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900156-1

7 January 2021

Increased serum soluble CD8 or suppressor/cytotoxic antigen concentrations in depression: suppressive effects of glucocorticoids.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900156-1

7 January 2021

Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900156-1

7 January 2021

Negative Immunoregulatory Effects of Antidepressants Inhibition of Interferon-γ and Stimulation of Interleukin-10 Secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900156-1

7 January 2021

Leukocytosis induced by microinjection of endogenous pyrogen or interleukin-1 into the preoptic and anterior hypothalamus.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900156-1

7 January 2021

Psychoneuroimmunology and the cytokine action in the CNS: implications for psychiatric disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900156-1

7 January 2021

Paroxetine for the prevention of depression induced by high-dose interferon alfa

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900156-1

7 January 2021

Alpha-1-acid glycoprotein in major depressive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900156-1

7 January 2021

Raised levels of plasma interleukin-1beta in major and postviral depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900156-1

7 January 2021

Anorexia during acute and chronic disease: relevance of neurotransmitter-peptide-cytokine interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900156-1

7 January 2021

Regulation of the human serotonin transporter by interleukin-1 beta

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900156-1

7 January 2021

Cytokines and the nervous system II: Actions and mechanisms of action

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900156-1

7 January 2021

Inflammatory markers in major depression and melancholia

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900156-1

7 January 2021

Cytokine production and serum proteins in depression

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900156-1

7 January 2021

Hypothalamic and thalamic sites of action of interleukin-1 beta on food intake, body temperature and pain sensitivity in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900156-1

7 January 2021

Hippocampal atrophy in recurrent major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900156-1

7 January 2021

Indicators of immune activation in major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900156-1

7 January 2021

Changes in immunoglobulin, complement and acute phase protein levels in the depressed patients and normal controls

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900156-1

7 January 2021

Interleukin-6 and the soluble IL-6 receptor are decreased in cerebrospinal fluid of geriatric patients with major depression: no alteration of soluble gp130

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900156-1

7 January 2021

Interleukin (IL) 1beta, IL-1 receptor antagonist, IL-10, and IL-13 gene expression in the central nervous system and anterior pituitary during systemic inflammation: pathophysiological implications

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900156-1

7 January 2021

Resistance to fever induction and impaired acute-phase response in interleukin-1 beta-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900156-1

7 January 2021

The relationship of depression and stressors to immunological assays: a meta-analytic review

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2801%2900156-1

7 January 2021

10.1016/S0753-3322(01)00156-1

Identifiers

DOI

1 reference

3 August 2017

1 reference